当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析

亚虹医药-U

(688176)

  

流通市值:30.87亿  总市值:46.51亿
流通股本:3.78亿   总股本:5.70亿

亚虹医药-U(688176)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润-3.86亿元,每股收益-0.68元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益197037.38万元,未分配利润-142861.52万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产222299.19万元,负债25261.81万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入201,562,432.59138,951,629.0380,493,424.4624,319,537.45
营业总成本609,000,649.86422,331,119.09275,421,295.92117,128,087.84
营业利润-383,805,943.59-268,659,981.92-184,430,587.26-83,313,061.22
利润总额-386,795,826.88-271,557,522.32-184,702,091.44-83,313,061.22
净利润-386,000,059.67-271,342,070.94-184,325,904.69-82,969,385.29
其他综合收益-5,208,757.06-2,291,721.15-3,994,091.88-1,115,257.61
综合收益总额-391,208,816.73-273,633,792.09-188,319,996.57-84,084,642.9
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计1,530,945,418.211,598,463,174.922,089,406,719.532,305,728,450.84
非流动资产合计692,046,485.58715,379,353.25354,605,395.25252,324,084.87
资产总计2,222,991,903.792,313,842,528.172,444,012,114.782,558,052,535.71
流动负债合计197,059,830.76177,890,199.89206,289,585.05203,168,340.65
非流动负债合计55,558,274.5356,303,371.3853,578,993.3654,642,466.4
负债合计252,618,105.29234,193,571.27259,868,578.41257,810,807.05
归属于母公司股东权益合计1,969,405,336.092,078,328,413.082,182,663,9322,298,581,382.99
股东权益合计1,970,373,798.52,079,648,956.92,184,143,536.372,300,241,728.66
负债和股东权益合计2,222,991,903.792,313,842,528.172,444,012,114.782,558,052,535.71
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计195,899,049.99128,580,141.1972,412,351.7926,465,560.01
经营活动现金流出小计620,849,902.16453,739,827.29315,254,586.9155,575,595.09
经营活动产生的现金流量净额-424,950,852.17-325,159,686.1-242,842,235.11-129,110,035.08
投资活动现金流入小计2,395,262,459.833,401,030,620.391,855,459,327.261,104,473,904.73
投资活动现金流出小计1,598,008,544.962,957,271,644.361,542,138,091.47550,057,471.22
投资活动产生的现金流量净额797,253,914.87443,758,976.03313,321,235.79554,416,433.51
筹资活动现金流入小计66,200,00036,500,00036,500,00036,500,000
筹资活动现金流出小计143,210,871.59105,856,986.4432,112,810.3112,678,974.68
筹资活动产生的现金流量净额-77,010,871.59-69,356,986.444,387,189.6923,821,025.32
汇率变动对现金及现金等价物的影响-1,954,293.65-232,028.76-7,577.18-1,256,726.15
现金及现金等价物净增加额293,337,897.4649,010,274.7374,858,613.19447,870,697.6
期末现金及现金等价物余额620,634,966.11376,307,343.38402,155,681.84775,167,766.25
最新报告期:2025-04-21
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
财通证券华挺,赵千,张文录-0.36-0.100.172025-04-21
TOP↑